Mounjaro®
Starting from £179.99/mo
Start journey Learn moreRestarting Mounjaro on 5mg after a break is possible, but it is almost always safer to go back to the 2.5mg starting dose first. The right re-entry dose depends on how long you were off treatment, why you stopped, and what your prescriber decides — because Mounjaro is a prescription-only medicine and every restart should be clinically reviewed. This page explains what the evidence and clinical guidance say about picking up treatment again, and what to expect when you do.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When tirzepatide is first introduced, the 2.5mg pen is there to give your digestive system a settling-in period. Nausea, vomiting and stomach cramps are most common in the early weeks, and the slow titration is designed to reduce that. When you stop treatment and then restart, your tolerance can reset (partially or fully) depending on how long the gap was.
A break of three or four days is unlikely to change much. A gap of several weeks, however, means your gut has had time to readjust to its pre-treatment normal. Jumping straight to 5mg in that situation is the equivalent of a new patient skipping the starter dose, and NHS guidance on tirzepatide is clear that dosing should follow the prescribed schedule, which exists for tolerability reasons.
None of this means 5mg is automatically off the table. Your prescriber will look at how long you were off, the reason you stopped (illness, a planned pause, a supply gap), your weight at restart, and how you tolerated each dose previously. That full picture (not the dose number alone) drives the decision. You can read more about what dose Mounjaro treatment begins on and why the titration is structured the way it is.
The Summary of Product Characteristics (the formal prescribing document) sets out the titration ladder: 2.5mg for four weeks, then 5mg, then optional increases of 2.5mg every four weeks up to the 15mg maintenance dose. It does not contain a specific protocol for restarting after a break, which is one reason clinical judgement matters so much here.
In practice, most prescribers follow a conservative rule of thumb: if you have been off treatment for four weeks or more, retitrate from 2.5mg. Shorter gaps may allow a return to the most recent dose, but that call belongs to your prescriber, not to a general article. The Mounjaro SmPC on the eMC is the authoritative reference if you want to read the full prescribing information yourself.
What the guidance does make clear is that patients who experience significant side effects at any dose should discuss with their prescriber whether to stay at the current level longer or step back down, and that principle applies equally to restarting. If you had a rough time at 5mg before your break, that history is exactly the sort of thing a prescriber needs to know.
For context on how the 5mg dose fits into the broader schedule, our Mounjaro 5mg page covers what this dose typically involves and who reaches it.
Yes, for some people it is entirely appropriate. If your break was short (say, under two weeks) and you tolerated 5mg well before stopping, many prescribers will be comfortable with you returning to that dose rather than spending another month on 2.5mg. The point of retitration is tolerability, not a rule for its own sake.
The honest answer is that this is genuinely a grey area, and the right answer varies person to person. Someone who paused for a week because of a holiday is in a very different position from someone who stopped for two months due to illness, and if you are weighing up whether starting on 5mg tirzepatide is appropriate for your circumstances, a prescriber who has seen your notes and can ask the right questions is much better placed to make this call than any fixed protocol could be.
At nume (sorry, at a service like ours) every repeat order and dose question is reviewed by a real clinician before a prescription is issued. If you are wondering whether your specific situation allows a restart at 5mg, that is exactly the question to put to your prescriber. Check whether a consultation is the right next step for you.
Gastrointestinal effects are the main thing to monitor: nausea, an unsettled stomach, loose stools or constipation. These tend to peak in the first few days after a dose change and often settle within a week or two. Going back to a higher dose after a gap can bring them back even if you had barely noticed them at that dose before.
Staying well hydrated helps, and eating smaller, lower-fat meals in the first week back makes a difference for most people, not because the medicine requires it by instruction, but because a full stomach on a sensitised gut is uncomfortable. Protein and fibre matter too, since appetite suppression can mean people unintentionally undereat during a restart.
More serious signs to take seriously: persistent severe stomach pain that reaches through to the back could suggest pancreatitis and needs urgent medical attention. That risk is low but real. The MHRA highlighted acute pancreatitis in a Drug Safety Update for GLP-1 medicines earlier in 2026, so it is on the radar of every prescriber working with these treatments. If anything feels off during a restart, contacting your prescriber or calling 111 is always the right move, not waiting it out. You can also report any suspected side effect via the MHRA Yellow Card scheme.
Questions about whether going straight to 5mg Mounjaro is safe are among the more common ones our prescribers field, and people also frequently ask whether you can start Mounjaro at 5mg in the first place, or put more directly, whether starting Mounjaro at 5mg is right for them personally, and the answer genuinely depends on the individual.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.